The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Aerovate Therapeutics, Inc. Common Stock 008064107   59,113,365 2,017,521 SH   SOLE   2,017,521 0 0
Akero Therapeutics, Inc. Common Stock 00973Y108   32,564,955 594,251 SH   SOLE   594,251 0 0
AVROBIO INC Common Stock 05455M100   3,222,923 4,520,863 SH   SOLE   4,520,863 0 0
Day One Biopharmaceuticals, Inc. Common Stock 23954D109   162,870,182 7,568,317 SH   SOLE   7,568,317 0 0
Disc Medicine, Inc. Common Stock 254604101   68,854,884 3,461,784 SH   SOLE   3,461,784 0 0
Dyne Therapeutics, Inc. Common Stock 26818M108   114,387,308 9,869,483 SH   SOLE   9,869,483 0 0
F-star Therapeutics, Inc. Common Stock 30315R107   3,788,992 599,524 SH   SOLE   599,524 0 0
Generation Bio, Co. Common Stock 37148K100   32,535,983 8,278,876 SH   SOLE   8,278,876 0 0
Ikena Oncology, Inc. Common Stock 45175G108   13,348,353 5,018,178 SH   SOLE   5,018,178 0 0
Kymera Therapeutics, Inc. Common Stock 501575104   149,379,011 5,984,736 SH   SOLE   5,984,736 0 0
MAGENTA THERAPEUTICS INC Common Stock 55910K108   1,373,232 3,476,536 SH   SOLE   3,476,536 0 0
Replimune Group, Inc. Common Stock 76029N106   57,073,760 2,098,300 SH   SOLE   2,098,300 0 0
SPERO THERAPEUTICS INC Common Stock 84833T103   1,783,907 1,031,160 SH   SOLE   1,031,160 0 0
Third Harmonic Bio, Inc. Common Stock 88427A107   46,903,794 10,907,859 SH   SOLE   10,907,859 0 0
Vigil Neuroscience, Inc. Common Stock 92673K108   72,960,925 5,836,874 SH   SOLE   5,836,874 0 0
Viridian Therapeutics, Inc. Common Stock 92790C104   2,631,003 90,072 SH   SOLE   90,072 0 0
Xilio Therapeutics, Inc. Common Stock 98422T100   7,422,635 2,759,344 SH   SOLE   2,759,344 0 0